INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

  • Paper COAs in 2026: It's Not Cheaper, It's Riskier

    Learn why sticking with paper records is a faulty strategy and discover how hidden costs, transcription errors, and regulatory red flags make digital COAs the only safe choice for modern trials.

  • 2025 Big Ideas In Clinical Trials: A Conversation

    Clinical trials are being redefined by three key forces: true patient-centricity, a rising focus on corporate responsibility and sustainability, and the push for greater efficiency through innovative designs.

  • Applying AI to Study Simulation: From Design to Analysis

    See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

  • Building One Home for Sites

    Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.

CLINICAL TRIAL TECHNOLOGY SOLUTIONS

  • Whether you’re archiving a TMF delivered by your CRO partner, looking to move out of noncompliant file systems, or interested in reducing the high costs of archiving in your active eTMF, IQVIA eArchive is the rapid deployment solution for you.

  • TrialScope Atlas enables clinical trial sponsors to quickly and accurately answer the question: Am I сompliant? Atlas reduces the risk of disclosure noncompliance by providing real-time access to consolidated, global compliance performance metrics.

  • Join industry leaders at the Clinical Trials Technology Congress to explore how digital innovation, patient-centric design, and real-world data are transforming the future of clinical trials.

  • Explore how this unified vaccine solutions platform integrates advanced tools for vaccine trials, offering unified data management that reduces silos, enabling efficient decision-making.

  • With 80% of trials failing to enroll patients on time, improved collaboration between sites and sponsors is essential to enhance study startup.